tirzepatide and psoriasis flare following initiation in a patient with plaque psoriasis in remission: A case report New Tirzepatide trial confirms benefits

JAMA Network Open, 6 (5), e2314493

The cost of a new vial is far less than the cost of injecting degraded or contaminated medication

The European market is characterized by strong safety and efficacy standards, driven by the high prevalence of diabetes and demand for innovative treatments

Providers increasingly field questions about BPC-157, making it important to understand the current evidence, the types on the market, and the regulatory landscape

Why does this guide single out diabetic retinopathy for closer monitoring

The stool analysis (GI effects test) identified growth of Candida albicans 2+, low bacterial diversity, and impaired fat absorption